Insulin Adjustments for Patients with Diabetes Starting Prednisone
For patients with diabetes starting prednisone therapy, NPH insulin is the preferred insulin formulation for managing steroid-induced hyperglycemia, with an initial dose of 0.1-0.2 units/kg administered in the morning to match the peak hyperglycemic effect of daily prednisone. 1
Understanding Prednisone's Effect on Blood Glucose
- Prednisone reaches peak plasma levels in 4-6 hours after administration but has pharmacologic actions that last throughout the day 2
- The typical glycemic pattern for patients on morning prednisone shows normal or mild fasting hyperglycemia, with increasing hyperglycemia during the afternoon, peaking in the evening 3
- Patients on morning steroid regimens have disproportionate hyperglycemia during the day but frequently reach normal blood glucose levels overnight 2
Insulin Adjustment Strategy
For Patients Already on Insulin:
- Increase total daily insulin dose by 30-50% during steroid treatment 4
- NPH insulin is particularly effective due to its peak action profile that aligns with the peak hyperglycemic effect of glucocorticoids 1
- For patients on high-dose glucocorticoids, insulin requirements may increase by 40-60% 5, 1
Initial Dosing Guidelines:
- For patients not previously on insulin: Start NPH at 0.1-0.2 units/kg per day administered in the morning 1
- For patients already on insulin: Increase basal insulin by 30-50% and administer as NPH in the morning 4, 6
- For high-dose prednisone (>40 mg/day): Use approximately 0.1 units/kg/10 mg prednisone equivalent dose 7
- For low to medium-dose prednisone (≤40 mg/day): Use approximately 0.3 units/kg/10 mg prednisone equivalent dose 7
Monitoring and Adjustment Protocol
- Monitor blood glucose 4 times daily during steroid therapy, with special attention to afternoon and evening values 4
- Check blood glucose 2-4 hours after steroid administration when hyperglycemic effect is maximal 4
- For persistent hyperglycemia, increase NPH dose by 2 units every 3 days until target blood glucose is achieved 1
- If hypoglycemia occurs, reduce NPH dose by 10-20% 1
Special Considerations
- For patients receiving enteral/parenteral nutrition while on steroids, NPH insulin can be administered two or three times daily (every 8 or 12 hours) 2, 3
- For long-acting glucocorticoids such as dexamethasone, long-acting basal insulin may be required instead of NPH 5, 2
- Insulin requirements typically decrease rapidly after steroid discontinuation, requiring prompt dose adjustments to avoid hypoglycemia 4
- Sulfonylureas are not recommended for managing steroid-induced hyperglycemia due to risk of prolonged hypoglycemia 4
Evidence-Based Outcomes
- A randomized clinical trial showed that an NPH insulin-based protocol significantly improved glycemic control in hospitalized patients receiving corticosteroids compared to usual care (mean blood glucose 226.12 vs. 268.57 mg/dL) 8
- Another randomized study found no significant differences in efficacy or safety between isophane (NPH) and glargine-based insulin regimens for steroid-induced hyperglycemia 6
By implementing this NPH-focused insulin adjustment strategy that matches the pharmacokinetic profile of prednisone, clinicians can effectively manage steroid-induced hyperglycemia while minimizing the risk of nocturnal hypoglycemia.